#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bone marrow disorder Alveolar proteinosis Oropharyngeal squamous cell carcinoma Basal cell naevus syndrome Sexually transmitted disease Enteritis Waldenstrom's macroglobulinaemia Arteriosclerosis Growth hormone deficiency Demyelination Nephroblastoma Primary mediastinal large B-cell lymphoma Atopic keratoconjunctivitis Hereditary ataxia Familial hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Encephalitis autoimmune – Basic Information Thrombotic thrombocytopenic purpura Adrenogenital syndrome – Trials in Disease Hereditary neuropathic amyloidosis – Treatment Erdheim-Chester disease – Diagnostics Adrenogenital syndrome – Diagnostics Langerhans’ cell histiocytosis – Basic Information X-linked lymphoproliferative syndrome Mantle cell lymphoma stage III – Treatment Richter’s syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Fludarabine Phosphate Betula Verrucosa Pollen Sodium Acetate (1-13C) Carbasalate Calcium Pralatrexate ALN-4324 NALDEMEDINE Colesevelam Cimetidine Hydrochloride Bi 1015550 Sugammadex ICOTROKINRA Edoxaban Idelalisib Stx-241 Magnesium Ro7269162 Cariprazine Hydrochloride Bexmarilimab Dmd06-Mab More therapies…

    Learn about Your Condition

    Thrombotic microangiopathy Agitation postoperative Malignant melanoma stage II Viral infection Post-traumatic headache Perineal injury Cachexia Haemolytic uraemic syndrome Osteosarcoma recurrent Aphthous ulcer Choreoathetosis Biotinidase deficiency Adenovirus infection Laryngeal cancer Bacteraemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of TIL therapy combined with peginterferon alfa-2a and nivolumab for patients with metastatic melanoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Metastatic malignant melanoma
    Investigated Drugs:
    • TIL CELLS
    • Zirconium (89Zr) Crefmirlimab Berdoxam
    The Netherlands

  • Study on the Effectiveness of Ublituximab and Drug Combination for Patients with Relapsing Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Cetirizine
    • Diphenhydramine
    • Gadobutrol
    Poland

  • Study on Virus-Specific T-Cells for Treating Resistant Viral Infections in Young Patients After Stem Cell Transplant

    Recruiting

    1 1 1
    Italy

  • Study of Atezolizumab, Paclitaxel, and Carboplatin for Patients with Stage IIIA and IIIB Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Paclitaxel
    Spain

  • Study Comparing Rifabutin and Rifampicin for Adults with Staphylococcal Prosthetic Joint Infection Using DAIR Strategy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifabutin
    • Rifampicin
    France

  • Study Comparing Ivonescimab to FOLFOX Drug Combination for Patients with Advanced Biliary Tract Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Calcium Levofolinate
    • Ivonescimab
    • Calcium Folinate
    France
Previous Page
1 … 286 287 288 289 290 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!